Study the Effect Of Aparpinda taila Matra basti in Vatarakta (GOUT)

EVALUATION OF THE EFFICACY OF APARPINDA TAILA MATRA BASTI IN THE MANAGEMENT OF VATARAKTA: A SINGLE ARM CLINICAL STUDY - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103254

Enrollment

Registered

2026-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Participants having classical sign and symptoms of Vatarakta. Participants with age group 18-60 yrs of either gender.

Exclusion criteria

Exclusion criteria: participants classically contraindicated for matra basti such as Jalodar,Atisar,etc. Known history of HIV, HbsAg positive participants.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Aparpinda Taila Matra basti in the management of Vatarakta.Timepoint: 15 days	—

Secondary

Measure	Time frame
Decreased in the symptoms of Shoola, Shotha, Twaka kandu, Twaka vaivarnya, Daha.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactVd Yashshree Naresh Sakharkar

Tilak Ayurved Mahavidyalaya, Pune

vdrahulkathawate@gmail.com7385201786

Outcome results